The Lymphoma Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
SOHO 2024 | Australasian Lymphoma Alliance consensus practice statement on the diagnosis and management of FL
Eliza Hawkes, MBBS Hons, FRACP, DMedSc, Olivia Newton-John Cancer Research Institute at Austin Health, Heidelberg, Australia, discusses a recently published consensus practice statement from the Australasian Lymphoma Alliance that focused on the diagnosis, management, and follow-up of follicular lymphoma (FL). Prof. Hawkes highlights the importance of individualized treatment approaches, emphasizing the need to consider the potential toxicities of available therapies, especially in older patients. This interview took place at the Twelfth Annual Meeting of the Society of Hematologic Oncology (SOHO 2024) congress in Houston, TX.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
